Exiqon
Home Search Contact Print Sign In
 
Products Services Resource Center Ordering About Exiqon
microRNA Research
mRNA & lncRNA Research
DNA Research
Custom LNA™ Oligos
LNA™ Phosphoramidites
RNA Isolation
Sequencing
Microarray Analysis
Real-time PCR
Northern Blotting
In Situ Hybridization
Functional Analysis
RNA Isolation
Sequencing
Microarray Analysis
Real-time PCR
In Situ Hybridization
Antisense
SNP Detection
Sequencing
Microarray Analysis
In Situ Hybridization
RNA Isolation Services
microRNA PCR Services
Sequencing Services
Custom Pharma Service
Documents
Application Stories
Movies
Contact
News
 

New Center of Excellence for microRNA qPCR services

We are happy to announce that the Oncogenomics Core Facility at University of Miami Sylvester Comprehensive Cancer Center has been selected as a Center of Excellence for microRNA qPCR services.

LNA™-enhanced microRNA real-time PCR profiling holds great promise as a non-invasive way to discover important new biomarkers for a wide range of diseases and biological processes. The extreme sensitivity obtained by inclusion of LNA™ in the PCR primers allows for accurate profiling of microRNA from any type of sample, including samples with low microRNA content such as serum, plasma and other biofluids.


Exiqon’s miRCURY LNA™ Universal RT microRNA PCR system is available in a wide range of formats: from single assays and focused microRNA panels to miRNome panels for global microRNA profiling. Let the Oncogenomics Core Facility analyze your samples in a format that suits your microRNA profiling project.

The Oncogenomics Core Facility offers complete service for:
  • miRNome PCR Panels
  • Serum/Plasma Focus microRNA PCR Panels
  • Cancer Focus microRNA PCR Panels
  • Individual microRNA LNA™ PCR Assays


“The Oncogenomics Core Facility has had great success over the last several months using the Exiqon LNA™ qPCR platform and we are excited to be a Center of Excellence”, said Toumy Guettouche, Ph.D., Core Director.
“We are pleased to announce the first Center of Excellence in North America”, said Henrik M. Pfundheller, PhD, SVP, Sales & Marketing and added: “The demand for profiling microRNAs from body fluids such as serum/plasma and urine is increasing at a fast rate and we are therefore happy to have the Oncogenomics Core Facility as part of our program”.
For more information, or to submit samples to your regional Exiqon LNA™ Center of Excellence for qPCR, please contact:

Toumy Guettouche, Ph.D.
Core Director
(305) 243-8410
tguettouche@med.miami.edu


  Privacy   Sitemap   Legal